NEW YORK (Reuters Health) Aug 28 –
Inhaled formoterol dry powder is an effective treatment for children with asthma that fails to respond to anti-inflammatory therapy, according to a report published in the August issue of the Annals of Allergy, Asthma, and Immunology.
Previous reports have shown that formoterol therapy improves lung function and reduces asthma symptoms in adults treated with anti-inflammatory drugs. However, the long-term efficacy of formoterol as add-on therapy in children with asthma has not been assessed
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!